UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Q: What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in Q1 2026?

172 institutional investors reported URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: M96088105

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares: 46,442,204
Total 13F value: $835,175,107
Share change: +2,684,270
Put/Call ratio: 76%
SEC-reported price per share: $17.98
Number of holders: 172
Value change: +$44,202,797
Number of buys: 78
Number of sells: 72
Shares outstanding: 48,684,257

Security key

M96088105

Report period

Q1 2026

Institutions

172

Top holders

URGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 UroGen Pharma Ltd. SEC filings UroGen Pharma Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M96088105

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

RTW INVESTMENTS, LP

Comparable rows

15/15

Latest evidence

31 Mar 2026

13F 13D/G Lead comparable stake: 5.4% 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 5.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 5.4%

TORONTO DOMINION BANK 5.4%

BlackRock, Inc. 5.2%

MENORA MIVTACHIM HOLDINGS LTD. 5%

Soleus Capital Master Fund, L.P. 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F 13D/G Company 13F 13D/G	5.4% from 13D/G	$60,023,155 2,562,901 shares	—	31 Dec 2025
TORONTO DOMINION BANK	13D/G The Toronto-Dominion Bank 13D/G	5.4%	$53,066,960 2,616,714 shares	+$6,375,626	31 Mar 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.2% from 13D/G	$60,915,631 2,601,009 shares	—	31 Dec 2025
MENORA MIVTACHIM HOLDINGS LTD.	13F 13D/G Company 13F 13D/G	5% from 13D/G	$26,992,276 1,152,531 shares	—	31 Dec 2025
Soleus Capital Master Fund, L.P.	13D/G 13D/G	4.7%	$31,114,400 2,185,000 shares	-$1,993,600	30 Jun 2025
Paradigm Biocapital Advisors LP	13F 13D/G Company 13F 13D/G	3.5% from 13D/G	$104,772,836 4,473,648 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

172

46,442,204

Rows available

172

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

172

Q1 2026 holders

172

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend